genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
From the Bench to Benchling
Drug Discovery
Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Coronavirus
A ‘Patch’-Work Solution to Vaccine Delivery
Bioinformatics
NVIDIA Powers Up in Drug Discovery
News
Antibodies
Cancer’s Spread Prevented by Blocking Signaling along the Lymphatic Route
AAV (Adeno-associated virus)
AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials
Gene Therapy
Lysogene Confirms Child’s Death in Phase II/III Gene Therapy Trial
Diabetes
How a Virus Can Trigger Diabetes
Cancer
FucoID: Fast, Precise Tool Identifies Tumor-Targeting T Cells
Insights
All
Trends for 2020
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Contract Manufacturer Sets Up for Fill-and-Finish Next-Generation Therapies
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Bioprocessing
Ori Biotech Raises $30 Million in Financing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibodies
Cancer’s Spread Prevented by Blocking Signaling along the Lymphatic Route
Upcoming Webinars
A Conversation with Jennifer Doudna, 2020 Nobel Laureate
AAV (Adeno-associated virus)
AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials
Gene Therapy
Lysogene Confirms Child’s Death in Phase II/III Gene Therapy Trial
Magazine
October 2020 Vol. 40 No. 10
Spatial: The Next Omics Frontier
October 2020 Vol. 40 No. 10
Gene Therapy Startups Extend Biotech’s Legacy
October 2020 Vol. 40 No. 10
Viral or Nonviral: Which Is Better for CRISPR-Based Therapies?
October 2020 Vol. 40 No. 10
The Chronicles of CRISPR
October 2020 Vol. 40 No. 10
Host Cell Protein Analysis Informs Risk Assessment
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Monoclonal Antibodies
Monoclonal Antibodies
7 days popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Monoclonal Antibodies
Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon
Monoclonal Antibodies
Otsuka to Acquire Visterra for $430M, Adding to Its Pipeline and...
Monoclonal Antibodies
Lonza to Provide Cell-Line and Process-Development Services for Athera’s mAb
Monoclonal Antibodies
Peaceable Gut Microbiota Express Symbiosis-Promoting Factors in Response to IgA
Monoclonal Antibodies
Engineered Gut Bacteria Reverse Type 1 Diabetes in Experimental Mice
Monoclonal Antibodies
Merck Serono Enters Biosimilar Segment in Deal with Dr. Reddy’s
Monoclonal Antibodies
RuiYi, CMC Collaborate to Speed mAb Development
Monoclonal Antibodies
Streamlining Glycan Analysis: From Sample Preparation to Data Analysis
Monoclonal Antibodies
Regeneron Enters Agreement with BARDA on Antibody Therapy for Ebola
Monoclonal Antibodies
Regeneron Joins Forces with the Icahn School of Medicine at Mount...
1
2
Page 1 of 2
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Genentech will tap Spirogen’s technology and Pfizer will use Seattle Genetics’.[Sebastian Kaulitzki-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesJan2011Jan6_2011_8300503_AntibodiesBlood_BIandMacroGenicsAntibodyDeal1727281211-324x160.jpg "Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon")
